SCHEMBL21596846

SCHEMBL21596846

COc1cc(OC(F)F)cc2onc(N)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.34
GAA P10253 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDR P35968 5/20 0.32
KIT P10721 3/20 0.32
NTRK1 P04629 3/20 0.32
LCK P06239 3/20 0.32
FGFR1 P11362 3/20 0.32
FLT3 P36888 3/20 0.32
MAP4K2 Q12851 3/20 0.32
ROCK1 Q13464 3/20 0.32
AURKB Q96GD4 3/20 0.32
AURKA O14965 2/20 0.32
ROCK2 O75116 2/20 0.32
RPS6KA5 O75582 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596934 0.78 ALDH1A1 (0.34) KDM4EALDH1A1HPGDCSF1RPDE2A
SCHEMBL31535761 0.76 CA12 (0.36) LTB4RGAAKDM4EALDH1A1LMNA
SCHEMBL21608946 0.74 KAT7 (0.36) KDM4EALDH1A1KDRKITNTRK1
SCHEMBL21609037 0.73 KAT6A (0.62) KAT6AKAT7KAT6B
Hydrochloric Acid SCHEMBL31535978 0.73 CYP3A4 (0.40) KDM4EKDRKITNTRK1LCK
SCHEMBL21596816 0.72 KAT6A (0.37) LTB4RKDRKITNTRK1LCK
SCHEMBL31432518 0.71 KAT6A (0.38) LTB4RGAAKDM4EALDH1A1HSD17B10
SCHEMBL25564465 0.71 KAT6A (0.38) LTB4RGAAKDM4EALDH1A1HSD17B10
SCHEMBL25566016 0.71 HCRTR1 (0.32) LTB4RGAAKDM4EALDH1A1LMNA
SCHEMBL21596808 0.71 KAT7 (0.39) KDRKITNTRK1LCKFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 LTB4R 2470/4885GAA 137/4885KDM4E 4009/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 LTB4R 2469/4885GAA 137/4885KDM4E 4009/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B LTB4R 4208/4885GAA 2370/4885KDM4E 800/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 LTB4R 2469/4885GAA 137/4885KDM4E 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.